Annual Cash & Cash Equivalents
$1.12 M
-$2.02 M-64.30%
December 31, 2023
Summary
- As of February 7, 2025, ENSC annual cash & cash equivalents is $1.12 million, with the most recent change of -$2.02 million (-64.30%) on December 31, 2023.
- During the last 3 years, ENSC annual cash & cash equivalents has risen by +$929.40 thousand (+478.58%).
- ENSC annual cash & cash equivalents is now -90.84% below its all-time high of $12.26 million, reached on December 31, 2021.
Performance
ENSC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.15 M
+$3.11 M+298.16%
September 30, 2024
Summary
- As of February 7, 2025, ENSC quarterly cash and cash equivalents is $4.15 million, with the most recent change of +$3.11 million (+298.16%) on September 30, 2024.
- Over the past year, ENSC quarterly cash and cash equivalents has increased by +$3.03 million (+269.67%).
- ENSC quarterly cash and cash equivalents is now -66.13% below its all-time high of $12.26 million, reached on December 31, 2021.
Performance
ENSC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ENSC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -64.3% | +269.7% |
| 3 y3 years | +478.6% | +269.7% |
| 5 y5 years | +478.6% | +269.7% |
ENSC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -90.8% | at low | -66.1% | +298.2% |
| 5 y | 5-year | -90.8% | +478.6% | -66.1% | +2038.8% |
| alltime | all time | -90.8% | +478.6% | -66.1% | +2038.8% |
Ensysce Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.15 M(+298.2%) |
| Jun 2024 | - | $1.04 M(-69.4%) |
| Mar 2024 | - | $3.40 M(+203.0%) |
| Dec 2023 | $1.12 M(-64.3%) | $1.12 M(-23.3%) |
| Sep 2023 | - | $1.46 M(-61.8%) |
| Jun 2023 | - | $3.83 M(+170.5%) |
| Mar 2023 | - | $1.42 M(-55.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $3.15 M(-74.3%) | $3.15 M(-30.1%) |
| Sep 2022 | - | $4.50 M(+20.6%) |
| Jun 2022 | - | $3.73 M(-55.8%) |
| Mar 2022 | - | $8.44 M(-31.2%) |
| Dec 2021 | $12.26 M(+6215.5%) | $12.26 M(+79.2%) |
| Sep 2021 | - | $6.85 M(-14.6%) |
| Jun 2021 | - | $8.01 M(+4025.5%) |
| Dec 2020 | $194.20 K | $194.20 K |
FAQ
- What is Ensysce Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Ensysce Biosciences?
- What is Ensysce Biosciences annual cash & cash equivalents year-on-year change?
- What is Ensysce Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Ensysce Biosciences?
- What is Ensysce Biosciences quarterly cash and cash equivalents year-on-year change?
What is Ensysce Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of ENSC is $1.12 M
What is the all time high annual cash & cash equivalents for Ensysce Biosciences?
Ensysce Biosciences all-time high annual cash & cash equivalents is $12.26 M
What is Ensysce Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, ENSC annual cash & cash equivalents has changed by -$2.02 M (-64.30%)
What is Ensysce Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ENSC is $4.15 M
What is the all time high quarterly cash and cash equivalents for Ensysce Biosciences?
Ensysce Biosciences all-time high quarterly cash and cash equivalents is $12.26 M
What is Ensysce Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, ENSC quarterly cash and cash equivalents has changed by +$3.03 M (+269.67%)